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Apoptosis involves in the pathogenesis of various cardiac abnormalities. This study intends to evaluate the eﬀects of Li-Fu
formulaoncardiacapoptosisinduced by hyper-cholesterol diet. Twenty-four maleGoldenSyrianhamsterswere randomlydivided
into Control, Cholesterol and Li-Fu formula groups. Histopathological analysis, western blotting and terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assays were performed to measure the eﬀects of Li-Fu formula on left ventricle.
Signiﬁcantlyreduced TUNEL-positive cells andmitochondria- dependent apoptosiswere observed in the left ventricle ofhamsters
from Li-Fu formula group compared to the Cholesterol group. Additionally, induced cardiac insulin like growth factor I receptor
(IGFIR)-dependent survival pathway was detected in the Li-Fu formulagroup compared to the Cholesterol group. Besides, minor
ﬁbrosis, increased collagen deposition, and myoﬁbril disarray was detected in the Cholesterol group, whereas the reductions
of collagen deposition and myoﬁbril disarray were observed in the Li-Fu formula group. This study demonstrated that Li-Fu
formula not only reduced the mitochondria-dependent apoptosis and ﬁbrosis, but also enhanced the IGF-I survival pathway in
the left ventricle from high cholesterol-fed hamsters. We suggest the protective eﬀects of Li-Fu formula on cardiac apoptosis and
therapeutic potentials against cardiovascular disease.
1.Introduction
Hyper-cholesterol diet is known as an important risk factor
that has been associated with many heart disorders including
cardiac apoptosis [1, 2]. The cell apoptosis in terminally
diﬀerentiated cardiomyocyte cells is a very critical patho-
logical mechanism. Many studies have demonstrated that
apoptosis may contribute to the loss of cardiomyocytes in
cardiomyopathy and is regarded as a predictor of adverse
outcomes in subjects with cardiac diseases or heart failure
[3–5]. However, activation of IGF-I is beneﬁcial to improve
cardiac functions. Several evidences have indicated that IGF-
I plays a crucial role in protection of cardiomyocytes and
low IGF-I levels are associated with high risk for myocardial
infarction and heart failure [6, 7]. Two major IGF-I signaling
pathways,includingRas-Raf-1-Mek-ERKand3-kinase(PI3-
kinase)-Akt pathways, have been linked to cardiac growth,
proliferation, and anti-apoptotic responses [8–11].
Both Fas-dependent and mitochondrial-dependent
apoptotic pathways are considered as major pathways2 Evidence-Based Complementary and Alternative Medicine
directly to cause cardiac apoptosis [12, 13]. The recruitment
of Fas-associated death domain (FADD) and pro-caspase
8 by Fas receptor oligomerization [12] initiates a death-
inducingsignal thatresults in the activation ofcaspase 8.The
activatedcaspase 8leadstocleavageofcaspase 3thatexecutes
the cell death program [14, 15]. A recent study reported the
induction of Fas-dependent cardiac apoptosis in neonatal
rat ventricular myocytes by predisposing hydrogen peroxide
[16]. Our recent study reported the Fas-dependent cardiac
apoptosis in Wistar rats that were treated with second-hand
smoke [17]. Additionally, another study reported that
cardiac Fas receptor-dependent apoptotic pathways were
more activated in obese rats’ hearts, which may provide
one of the possible apoptotic mechanisms for developing
cardiac abnormality in obesity [18]. The mitochondrial-
dependent cell death is known as the intrinsic apoptotic
pathway that is mediated by internal factors, especially
in mitochondria where is the main site of action for the
apoptosis-regulating proteins such as the members of
B-cell CLL/lymphoma 2 (Bcl-2) family [12]. Occurrence of
mitochondrial-dependent apoptosis is typically governed by
contradicting the Bcl-2 family [19]. Bcl-2 is a well-known
anti-apoptotic protein that can prevents cytochrome c
release whereas Bax (Bcl-2-associated X protein) and Bad,
pro-apoptotic proteins, enhance cytochrome c release from
mitochondria into cytosol [12], which is responsible for
activating caspase 9, caspase 3 and facilitates the apoptosis
[20]. Numerous studies have indicated the mitochondrial-
dependent cardiac apoptosis in rats that were received
diﬀerent treatments, including cocaine, mechanical stretch
and alcohol [21–23]. Naturally, interruption of apoptosis
could allow development of novel strategies to reverse or
attenuate heart disorders [24].
Various western drugs such as angiotensin-converting
enzyme inhibitors [25], calcium channel blockers [26],
angiotensin II receptor antagonists [27] have been widely
used in cardio-protective treatments. But the side eﬀects
could not be disregarded. In recent years, growing studies
were performed to investigate the natural products for the
cardio-protective eﬀects that have been used as drugs or diet
supplementsfor a long history inmany medical-experiences.
Various oriental herb extracts or dietary supplements have
been adoptedin preventing cardiac abnormality or disorders
including Fructus crataegi, Salvia miltiorrhiza and Astragali
radix.Thequercetinisthemain ingredientinFructuscrataegi
that has been demonstrated as an anti-inﬂammatory sub-
stance by inhibiting TNF-α release from macrophages [28].
Recently, the Fructus crataegi has also been reported to have
cardiac protective eﬀect in many medical-experiences [29].
Salvia miltiorrhiza is known as “Danshen” and mainly com-
posed of sodium tanshinone IIA sulfonate (STS),a derivative
oftanshinoneIIA.STScanreducemyocardialinfarctsizeand
prolong the survival cardiac cell in rabbit and human [30–
32]. These ﬁndings support the beneﬁcial eﬀect of STS in
protecting the heart. A. radix contains many isoﬂavones and
isoﬂavonoids, such as formononetin, calycosin and ononin,
and many saponins, such as astragaloside IV, astragaloside
II, astragaloside I, and acetylastragaloside I [33]. A. radix has
demonstrated the eﬀects against inﬂammation and cardiac
ischemia reperfusion injury and has been suggested the
protective eﬀect on heart [34–36].
In the current study, to understand the eﬀects of Li-
Fu formula on cardiac protection, we examined not only
the Fas-dependent and mitochondrial-dependent apoptosis
but also the IGF-I survival pathway in the cardiac tissues
from hamsters that were fed with a hypercholesterol diet.
We suggested the cardiac protective eﬀect of Li-Fu formula
by activating the IGF-I survival pathway and inhibiting
the cardiac mitochondria-dependent but not Fas-dependent
apoptosis.
2.Methods
2.1. Animals and Diet. A total of 24 male Golden Syrian
hamsters weighting 145–170g at the age of 8 weeks were
purchased from National Laboratory Animal Center, Taipei,
Taiwan, andusedinthisexperiment.Hamsterswere acclima-
tized for 2 weeks while receiving free access to water and were
fed chow diet (Lab Diet 5001; PMI Nutrition International
I n c . ,B r e n t w o o d ,M O ,U S A )a dl i b i t u m .T h eh a m s t e r sw e r e
then randomized into three groups as control, cholesterol
and Li-Fu formula groups and switched to experimental
diets. The control, cholesterol and Li-Fu formula groups
received chow diet, chow diet with 0.2% cholesterol (Sigma,
St Louis, MO, USA), and chow diet with 0.2% cholesterol
and 2% Li-Fu formula for 8 weeks, respectively. The Li-Fu
formula was ﬁrstly created and provided by Dr. Li-Fu Chen,
China Medical University, Taichung, Taiwan. To make Li-Fu
formula,everycomponentofdesiredweightwascrushedand
mixedwithablender,thenplacedindistilledwater(1000ml)
and boiled for 1h under reﬂux. The resultant solution was
divided into several parts and stored in a –80◦C freezer
for further use. Formulation and calculated composition
of experimental diets were shown in Table 1.T h ea m b i e n t
temperature was maintained at 25◦C. Diets were prepared
w e e k l ya n ds t o r e da t– 8 0 ◦C. All experimental procedures
were performedaccordingtotheNIHGuidefortheCareand
Use of Laboratory Animals. All protocols were approved by
the Institutional Animal Care and Use Committee of China
Medical University, Taichung, Taiwan. Food intake and food
spillage were measured daily, and body weight was recorded
every 3 days.
2.2.Transferase-Mediated dUTP Nick End Labeling (TUNEL).
After the hearts were excised, the hearts were soaked in
formalin and covered with wax. In heart tissues, the 3-
μmt h i c kp a r a ﬃn sections were cut from formalin-ﬁxed,
paraﬃn-embedded tissue blocks. The sections were deparaf-
ﬁnized by immersing in xylene, re-hydrated, and incubated
in phosphate-buﬀered saline with 2% H2O2 to inactivate
endogenous peroxidases. The sections were then incubated
with proteinase K (20μg/ml), washed in phosphate-buﬀered
saline, and incubated with terminal deoxynucleotidyl trans-
ferase for 90min and ﬂuorescein isothiocyanate-dUTP for
30min at 37◦C using an apoptosis detection kit (Roche
Applied Science, Indianapolis, IN, USA). Samples were
analyzed in a drop of PBS under a ﬂuorescence and UV light
microscope at this state by an excitation wavelength in theEvidence-Based Complementary and Alternative Medicine 3
Table 1: Formulation and calculated composition of experimental
diets.
Ingredients (% wt/wt) Control Cholesterol Li-Fu formula
Chow diet, (Rodent 5001) 99.5 99.3 97.3
Soybean oil 0.5 0.5 0.5
Cholesterol 0 0.2 0.2
Li-Fu formula
Celery(a) 0 0 0.05
Black fungus(b) 0 0 0.646
Mushroom(c) 0 0 0.848
Saliva miltiorrhiza 0 0 0.152
Crataegi cuneata 0 0 0.152
A. stragali radix 0 0 0.152
(a)Celeryis alsoknown as Apium graveolens; (b)Black fungus indicates Wood
ear, or pinyin: m` uˇ er, lit. “wood ear” or “tree ear” are commonly sold
in Asian markets as dietary supplement; (c)The standard for the name
“mushroom” is the cultivated white button mushroom, Agaricus bisporus.
range of 450–500nm and detection in the range of 515–
565nm. The number of TUNEL-positive cardiac myocytes
was determined by counting 3 × 105 cardiac myocytes. All
morphometric measurements wereperformedbyatleasttwo
independent individuals in a blinded manner.
2.3. Tissue Extraction. Cardiac tissue extracts were
obtained by homogenizing the left ventricle samples in
aP B Sb u ﬀer (0.14M NaCl, 3mMKCl, 1.4mMKH2PO4,
14mMK2HPO4) at a ratio of 100mg tissue/0.5ml PBS for
5min. The homogenates were placed on ice for 10min and
then centrifuged at 12 000g for 30min. The supernatant was
collected and stored at –70◦C for further experiments.
2.4. Electrophoresis and Western Blot. T h et i s s u ee x t r a c t
samples were prepared as described in Methods section.
Sodiumdodecyl sulfate-polyacrylamide gel electrophoresis
was performed with 10% polyacrylamide gels. Protein
concentration was determined using a BioRad Protein Assay
(BioRad Laboratories, Hercules, CA, USA) and were quan-
tiﬁed by absorbance at 595nm using a spectrophotometer
(Beckman Coulter, Palo Alto, CA, USA). The samples were
electrophoresed at 140V for 3.5h and equilibrated for
15min in 25mM Tris–HCl, pH 8.3, containing 192mM
glycine and 20%(V/V) methanol. Electrophoresed proteins
were transferred to nitrocellulose membranes (Amersham,
Hybond-C Extra Supported, 0.45μm pore size) with a Bio-
Rad Scientiﬁc Instruments Transphor Unit at 100mA for
14h. Nitrocellulose membranes were incubated at room
temperature for 2h in blocking buﬀer containing 100mM
T r i s – H C l ,p H7 . 5 ,0 . 9 %( w / v )N a C l ,0 . 1 %( v / v )f e t a lb o v i n e
serum. Antibodies including Fas, Bad, Bcl-2, cytochrome
c, caspase 8, IGFI receptor, PI3K, p-AKT, AKT, α-tubulin
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), cleaved
caspase 3 (Asp175) and cleaved caspase 9 (Asp315) (Cell
Signaling, MA, USA) were diluted to 1:200 in antibody
binding buﬀer containing 100mM Tris–HCL, pH 7.5, 0.9%
(w/v) NaCl, 0.1% (v/v) Tween-20 and 1% (v/v) fetal bovine
serum. Incubationswere performed atroomtemperaturefor
3.5h. The immunoblots were washed three times in 50ml
blotting buﬀer for 10min and then immersed in the second
antibody solution containing horseradish peroxidase (HRP)
conjugatedgoatanti-hamster IgG(Promega Corp.,Madison,
WI, USA) for 1h that was diluted 1000-fold in binding
buﬀer.Theimmunoblotswerethenwashedinblottingbuﬀer
for 10min three times. Pierce’s; Supersignal West Dura
HRPDetectionKit (Pierce Biotechnology Inc., Rockford,IL)
was used to detect antigen–antibody complexes. The blots
were scanned and quantiﬁed by densitometry (Appraise,
Beckman–Coulter, Brea, California, USA).
2.5. Masson Trichrome Staining. The hearts of animals were
excised, and were soaked in formalin and covered with wax.
Slides were prepared by deparaﬃnization and dehydration.
They were passed through a series of graded alcohols (100,
95 and 75%), 15min each. The slides were then dyed with
Masson trichrome. After gently rinsing with water, each slide
was then soaked with 85% alcohol, 100% alcohol I and II
for 15min each. At the end, they were soaked with Xylene I
and Xylene II. Photomicrographs were obtained using Zeiss
Axiophot microscopes.
2.6. Statistical Analysis. All the statistical analyses were
performed using SPSS10.0software (SPSSInc.,Chicago,IL).
Three independent experiments were repeated. Statistical
analyses were performed using the analysis of variance plus
posterior multiple comparison test to test the diﬀerence. The
databetweentwoexperimental animal groupswascompared
by Student’s t-test for two independent samples. In all cases,
ad i ﬀerence at P < .05 was considered statistically signiﬁcant.
3.Results
3.1. TUNEL-Positive Apoptotic Cells of Cardiac Tissues. To
investigate the eﬀect of Li-Fu formula on hyper-cholesterol
diet induced apoptosis in cardiac cells, we examined the
apoptosis-positive cardiac cells in the excised hearts of ham-
sters from Control, Cholesterol and Li-Fu formula groups
by TUNEL assay. We found that left ventricle stained with
TUNEL assay showed increased TUNEL-positive cardiac
cells in the Cholesterol group compared to the Control
group (Figure 1(a)). Notably, signiﬁcantly reduced TUNEL-
positive cardiac cells were found in the left ventricle of
hamsters fromLi-FuformulagroupcomparedtotheCholes-
terol group (Figure 1(a)).The percentageofTUNEL-positive
cardiac cells was calculated and the quantiﬁed results were
shown in Figures 1(b).
3.2.Eﬀect of Li-Fu FormulaonCardiac Fas and Mitochondrial-
Dependent Apoptotic Pathway. To further understand the
cardiac Bcl-2 family in mitochondrial-dependent apoptosis,
we examined the protein levels of the Bcl-2 family (Bad, Bcl-
2) in the excised hearts of hamsters from Control, Choles-
terol and Li-Fu formula by western blotting. The expression
of Bad protein was signiﬁcantly increased in the Choles-
terol group whereas anti-apoptotic proteins Bcl-2 were4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: (a) Representative stained apoptotic cells of cardiac
sections from left ventricles in hamsters of Control, Cholesterol
and Li-Fu formula groups were measured by staining with 4 ,6-
diamidino-2-phenylindole (DAPI) (left panels) and TUNEL assay
with dark background (right panels). The images were magniﬁed
by 400×. (b) Bars present the percentage of TUNEL positive cells
relative to total cells (6 rats × 30 scope ﬁeld count in each group).
∗∗P < .01, signiﬁcant diﬀerences between Control and Cholesterol
group. ##P < .01, signiﬁcantdiﬀerences between Cholesterol and Li-
Fu formula groups.
signiﬁcantly reduced in the Cholesterol group (Figure 2).
Notably, we found that signiﬁcantly reduced Bad and
increased Bcl2 protein expression in the excised hearts of
hamstersfromLi-FuformulagroupcomparedtotheCholes-
terol group (Figure 2). Quantiﬁed protein level and the fold
changes were shown in Figures 2(b) and 2(c).M o r e o v e r ,t h e
presence of cytosolic cytochrome c (cytochrome c release
from mitochondria), caspase 9 and caspase 3 in the excised
hearts of hamsters from Control, Cholesterol and Li-Fu
formulawereanalyzedbywesternblotting.Theproteinlevels
of cytochrome c, caspase 9 and caspase 3 were signiﬁcantly
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Figure 2: (a) The representative protein products of Bad and Bcl-
2 extracted from the left ventricles of excised hearts in hamsters of
Control, Cholesterol and Li-Fu formula groups were measured by
western blotting analysis. ((b) and (c)) Bars represent the relative
protein quantiﬁcation of Bad and Bcl-2 on the basis of α-tubulin.
Allbars indicatemeanvalues ± SD(n= 6i ne ac hgr ou p ).∗∗P <.01,
signiﬁcant diﬀerences between Control and Cholesterol group. ##P
<.01,signiﬁcantdiﬀerences between CholesterolandLi-Fu formula
groups.
increased in the Cholesterol group compared to the control
group. In contrast, signiﬁcantly reduced cytochrome c,
caspase 9 and caspase 3 were detected in excised left ventricle
of hamsters from Li-Fu formula group compared to the
Cholesterol group (Figure 3). Quantiﬁed protein levels and
the fold changes of cytochrome c, activated caspase 9 and
activated caspase 3 were shown in Figures 3(b), 3(c),a n d
3(d), respectively. To identify the downstream components
of cardiac Fas-dependent apoptotic pathway, we examined
the protein levels of Fas and caspase 8 in the excised hearts
of hamsters from Control, Cholesterol and Li-Fu formulaEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: (a) The representative protein products of cytosolic cytochrome c, caspase 9 and caspase 3 extracted from the left ventricles of
excised hearts in hamsters of Control, Cholesterol and Li-Fu formula groups were measured by western blotting analysis. ((b), (c), and (d))
Bars represent the relative protein quantiﬁcation of cytosolic cytochrome c, caspase 9 and caspase 3 on the basis of α-tubulin and indicate
mean values ± SD (n = 6i ne a c hg r o u p ) .∗∗P < .01, signiﬁcant diﬀerences between Control and Cholesterol group. ##P < .01, signiﬁcant
diﬀerences between Cholesterol and Li-Fu formula groups.
by western blotting. However, no signiﬁcant variation was
observed among the three groups of hamsters (Figure 4).
Quantiﬁed protein levels of Fas and caspase 8 were revealed
in Figures 4(b) and 4(c), respectively.
3.3. Eﬀect of Li-Fu Formula on Cardiac IGFIR-Dependent
Survival Signaling Pathway. To identify the eﬀect of Li-Fu
formula on cardiac IGFIR dependent survival pathway, we
examined the protein levels of IGFI receptor, PI3K, AKT
and p-AKT in the excised hearts of hamsters from Control,
Cholesterol and Li-Fu formula by western blotting. The pro-
tein levels of IGFI receptor, PI3K, AKT and phosphorylated
AKT were signiﬁcantly reduced in the left ventricle of ham-
sters from Cholesterol group compared to Control group
(Figure 5(a)). Notably, we found signiﬁcantly increased
IGFI receptor, PI3K, AKT and phosphorylated AKT in
the excised left ventricles of hamsters from Li-Fu formula
group compared to the Cholesterol group (Figure 5(a)).6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: (a) The representative protein products of Fas receptor
and caspase 8 extracted from the left ventricles of excised hearts in
hamsters of Control, Cholesterol and Li-Fu formula groups were
measured by western blotting analysis. ((b) and (c)) Bars represent
the relative protein quantiﬁcation of Fas receptor and caspase 8 on
thebasisofα-tubulin, andindicatemean values ±SD(n = 6i ne ac h
group).
Quantiﬁed protein levels and the fold changes of IGFI
receptor and phosphorylated AKT were shown in Figures
5(b) and 5(c), respectively.
3.4. Cardiac Fibrosis Changes. To examine the eﬀect of Li-
Fu formula on cardiac ﬁbrosis in hamsters, we performed
a histopathological analysis of ventricular tissue with
Masson-trichrome staining. Hearts stained with Masson-
trichrome showed minor ﬁbrosis, increased collagen deposi-
tion, and myoﬁbril disarray in Cholesterol group compared
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Figure 5: (a) The representative protein products of IGFIR, PI3K,
p-AKT and AKT extracted from the left ventricles of excised hearts
in hamsters of Control, Cholesterol and Li-Fu formula groups
were measured by western blotting analysis. ((b) and (c)) Bars
represent the relative protein quantiﬁcation of IGFI receptor and
phosphorylated AKT on the basis of α-tubulin, and indicate mean
values ± SD (n = 6i ne a c hg r o u p ) .∗∗P < .01,signiﬁcantdiﬀerences
between Control and Cholesterol group. ##P < .01, signiﬁcant
diﬀerences between Cholesterol and Li-Fu formula groups.
to the Control group (Figure 6). Notably, signiﬁcantly
reduced collagen deposition, and myoﬁbril disarray was
observed in the Li-Fu formula group compared to the
Cholesterol group (Figure 6).
4.Discussion
Apoptosis is known to play crucial roles and regarded as
a predictor in various cardiac diseases or heart failure [3,
5, 24]. Since the side eﬀects of western drugs in treatmentEvidence-Based Complementary and Alternative Medicine 7
Control Cholesterol Li-Fu formula
Figure 6: Representative histopathological analysis of cardiac tissue sections with Masson-trichrome staining (ﬁbrosis) in hamsters of
Control, Cholesterol and Li-Fu formula groups. The images of myocardial architecture were magniﬁed 100×.
Li-Fu formula
IGF1
p-AKT Bad
p-Bad
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Cytochrome c release
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Cardic apoptosis
Figure 7: The eﬀects of Li-Fu formula on hypercholesterolemia-
induced mitochondrial-dependent apoptotic pathway in ham-
sters. Our proposed integrative hypothesis indicates that car-
diac mitochondrial-dependent apoptotic pathway is more active
under hypercholesterolemia, whereas IGF-PI3K-Akt is down reg-
ulated. The decreased IGF-1, phosphorylated Akt, decreasaed
Bcl2, phosphorylated Bad, increased pro-apoptotic Bad, increased
cytochrome c release, increased activated-caspase 9 and increased
caspase 3 were detected in the heart of hypercholesterolemia
hamaster. The arrow represents its increasing or decreasing under
the condition of hypercholesterolemia. All these changes can be
suppressed by Li-Fu formula treatment.
of cardiac diseases cannot be avoided, the investigation
of natural products or dietary supplements to protect
cardiac abnormality and injury is essential. This study ﬁrstly
demonstrated the protective eﬀects of Li-Fu formula on
cardiac apoptosis in hamsters that were fed with a high-
cholesterol diet. Our results revealed that Li-Fu formula not
only reduced the mitochondria-dependent apoptosis and
ﬁbrosis, but also enhanced the IGF-I survival pathway in the
left ventricle from high cholesterol-fed hamsters.
Excess dietary cholesterol is responsible for the hyperc-
holesterolemiathathasbeenrecognizedasthesigniﬁcantrisk
factor to cause cardiac injury or diseases [37]. A recent study
reported that hypercholesterolemia reduced endomyocardial
coronaryﬂowreserve,capillarydensityandinducedcapillary
endothelial cell apoptosis in minipigs [38]. Another study
indicated the induction of coronary atherosclerosis and
myocardial ﬁbrosis in rabbits fed with hypercholesterol diet
[39]. Since the increased TUNEL-positive cardiac cells were
detected in hypercholesterol rabbits [40], the cardiac apop-
toticpathwayinducedbyhypercholesteroldietisstillunclear.
In our experimental ﬁndings, mitochondrial-dependent car-
diac apoptosis was signiﬁcantly increased in excised left
ventricle from hamsters fed with a high-cholesterol diet
(Figure 7). However, no variation of Fas-dependent apop-
totic components was detected in all hamsters. Therefore, we
suggested the Fas-independent but mitochondrial associated
cardiac apoptosis in hamsters that were fed with a high-
cholesterol diet.
IGF-I is a survival factor in cardiomyocytes that activates
the PI3K-Akt/PKB pathway [9]. The IGF-I can bind to
cell surface IGF-IR and cause a conformational change
resulting in activation of its tyrosine kinase domain and
autophosphorylation of tyrosine and serine residues [41,
42]. Once activated, the IGF-IR causes phosphorylation of
various proteins including insulin receptor substrate (IRS)-1
and IRS-2 [43]. Recent reports have indicated that increased
Bcl-xL level in mitochondrial was observed in IGF-I pre-
treated ratsand cardiac-speciﬁc IGF-I overexpression is anti-
apoptotic [44] whereas increased apoptosis after myocardial
infarction was observed in IGF-I deﬁcient mice [45]. As
consistent with our experimental results, the signiﬁcant
reduction of IGF-IR pathway associated components was
detected in the excised ventricle from hamster of Cholesterol
group. In contrast, signiﬁcantly increased IGFIR signaling
components and reduced cardiac apoptosis were observed in
the Li-Fuformulagroup.These ﬁndings suggested thatLi-Fu
formula attenuates the cardiac apoptosis and facilitates the
IGF-IR cardiac survival pathway (Figure 7).
The use of dietary supplements or herbal medicine for
the treatment of various disorders including heart diseases
has a long and extensive history. In the world, more than8 Evidence-Based Complementary and Alternative Medicine
half of the population relies on traditional medicine for
therapeutic needs either by stewing or solution extracting
[46, 47]. Although the precise mechanism of most herbal
medicine or dietary supplement has not been fully under-
stood, the experience of the traditional use over the years
cannot be neglected. The Li-Fu formula, initially created
by Dr Li-Fu Chen, China Medical University, Taichung,
Taiwan, is composed of Celery, Black fungus, Mushroom,
Saliva miltiorrhiza, Crataegi cuneata and A. radix as shown
in Table 1. Li-Fu formula is not only a formula of tradi-
tional herbal medicines but also routinely used as dietary
supplements. Additionally, the ingredient of Li-Fu formula
from diﬀerent batches has the very similar compositions
that are in acceptable inaccuracy. Moreover, Li-Fu formula
from diﬀerent batches has the same eﬀects on cardiac
protection. Since the major components of Li-Fu formula
have been suggested to have various cardiac protective eﬀects
[26, 27, 30–32, 35, 36], the precise actions on prevention
of hypercholesterolemia-induced cardiac apoptosis are still
unclear. In the current study, we have demonstrated the
beneﬁcial eﬀects of Li-Fu formula by signiﬁcantly reducing
cardiac ﬁbrosis, mitochondrial-dependent apoptosis and
activating of IGF-IR survival pathway and suggest the
potential of Li-Fu formula on cardiac protection.
Taken together, we demonstrated the mitochondria-
dependent but not Fas-dependent cardiac apoptosis in ham-
stersfedwithhypercholesteroldiet,andsuggestedthecardio-
protective eﬀect on activating the IGF-IR survival pathway
by treatment of Li-Fu formula. Although the mechanism of
Li-Fu formula on cardio-protective eﬀects is not completely
understood because of the limitation of research methodol-
ogy and complexity of Chinese traditional medicine, further
works are merited to be performed with single compound
such as STS, quercetin, formononetin, calycosin and ononin
to re-examine the eﬀects of these compounds.
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